NUBP2 Antibody, FITC conjugated

Shipped with Ice Packs
In Stock

Description

Key Observations on Antibody Characterization

The provided sources detail antibodies against CD34 , GM130/GOLGA2 , and NUFIP2 , all conjugated with FITC. While these are distinct targets, their documentation illustrates common features of FITC-conjugated antibodies:

Critical Quality Metrics

ParameterSpecificationSource
ConcentrationVial-specific (e.g., 2–5 µg/mL)
Stability4°C storage in dark
ApplicationsFlow cytometry, ICC/IF, IHC, WB
Cross-reactivityHuman, mouse, rat

FITC-Labeling Considerations

A critical study highlights that FITC conjugation impacts antibody performance:

  • Labeling index inversely correlates with antigen-binding affinity.

  • Over-labeling increases nonspecific staining in immunohistochemistry.

  • Recommendations:

    • Use antibodies with experimentally validated labeling ratios

    • Optimize dilutions for each application

Comparative Analysis of Documented FITC-Antibodies

TargetCatalog #HostApplicationsKey Data Available
GM130/GOLGA2NBP2-53420FRabbitFC, ICC/IF, IHC, WBImmunofluorescence images
NUFIP2ab221639RabbitICC/IFCaco-2 cell staining
CD34NBP2-47911FHumanFlow cytometry N/A

Limitations and Recommendations

  • No sources mention "NUBP2". Potential candidates:

    • NUFIP2 (Nuclear FMR1-interacting protein 2)

    • NUBP1/2 (Cytosolic iron-sulfur protein assembly factors) – absent in provided data.

  • For hypothetical NUBP2 studies:

    • Follow GM130 antibody protocols for ICC/IF optimization.

    • Validate labeling efficiency per to minimize affinity loss.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Typically, we can ship products within 1-3 business days after receiving your order. Delivery times may vary depending on the purchasing method and location. Please consult your local distributor for specific delivery timelines.
Synonyms
C447E6.1 (nucleotide binding protein 1 (E.coli MinD like) ) antibody; CFD1 antibody; Cytosolic Fe-S cluster assembly factor NUBP2 antibody; D17Wsu11e antibody; Homolog of yeast cytosolic FeS cluster deficient 1 antibody; NBP 2 antibody; NUBP1 antibody; Nubp2 antibody; NUBP2_HUMAN antibody; Nucleotide binding protein 2 (E.coli MinD like) antibody; Nucleotide binding protein 2 (MinD homolog, E. coli) antibody; Nucleotide binding protein 2 antibody; Nucleotide-binding protein 2 antibody
Target Names
NUBP2
Uniprot No.

Target Background

Function
NUBP2 is a component of the cytosolic iron-sulfur (Fe/S) protein assembly (CIA) machinery. It is essential for the maturation of extramitochondrial Fe-S proteins. The NUBP1-NUBP2 heterotetramer forms an Fe-S scaffold complex, facilitating the de novo assembly of an Fe-S cluster and its subsequent transfer to target apoproteins. Notably, NUBP2 plays a regulatory role in cilium formation and structure, exhibiting a negative regulatory effect.
Database Links

HGNC: 8042

OMIM: 610779

KEGG: hsa:10101

STRING: 9606.ENSP00000262302

UniGene: Hs.256549

Protein Families
Mrp/NBP35 ATP-binding proteins family, NUBP2/CFD1 subfamily
Subcellular Location
Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm. Cytoplasm, cytoskeleton, cilium axoneme. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole. Cytoplasm, cytoskeleton, microtubule organizing center.
Tissue Specificity
Widely expressed with highest expression in skeletal muscle.

Q&A

What is NUBP2 and why is it important in cellular research?

NUBP2 (Nucleotide-binding protein 2) functions as a component of the cytosolic iron-sulfur (Fe-S) protein assembly machinery. It plays a critical role in the maturation of extramitochondrial Fe-S proteins and has been implicated in regulating cilium formation and structure. NUBP2 is an MRP/MinD-type P-loop NTPase with sequence similarity to bacterial division site-determining proteins and is conserved throughout eukaryotes. Research shows it negatively regulates ciliogenesis, making it a crucial target for studying cellular development and function .

What are the storage and handling recommendations for NUBP2 Antibody, FITC conjugated?

For optimal results, NUBP2 Antibody, FITC conjugated should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided to maintain antibody integrity and fluorescence. The antibody is typically provided in liquid form with a buffer composition of 0.03% Proclin 300 as preservative, 50% glycerol, and 0.01M PBS at pH 7.4 . When working with FITC-conjugated antibodies, it's important to protect them from light exposure to prevent photobleaching of the fluorophore, as FITC is susceptible to photodegradation .

What species reactivity can be expected with NUBP2 Antibody, FITC conjugated?

The commercially available NUBP2 Antibody, FITC conjugated has confirmed reactivity with human samples . Some variants also demonstrate cross-reactivity with mouse and rat samples, allowing for comparative studies across these mammalian models . For research involving other species, validation experiments are strongly recommended prior to application in critical studies.

How does FITC conjugation affect antibody performance and detection?

FITC (Fluorescein Isothiocyanate) conjugation enables direct visualization of the antibody through fluorescence techniques. FITC is conjugated to proteins via primary amines (lysines), with typically 3-6 FITC molecules per antibody. Higher conjugation rates can lead to solubility problems and internal quenching, reducing brightness. The fluorophore is excited at 495 nm with emission at 519 nm, making it compatible with standard FITC filter sets in fluorescence microscopy and flow cytometry . When designing multi-color experiments, researchers should consider spectral overlap with other fluorophores.

What are the recommended dilutions and applications for NUBP2 Antibody, FITC conjugated?

NUBP2 Antibody, FITC conjugated has been validated for ELISA applications . For immunofluorescence and immunohistochemistry-paraffin (IHC-P) applications, recommended dilutions generally range from 1:50 to 1:200, though optimal dilutions should be determined experimentally for each specific application and protocol . When adopting methods from similar FITC-conjugated antibodies, researchers should consider that typical applications may include flow cytometry, immunocytochemistry/immunofluorescence, immunohistochemistry, and western blot, each requiring specific optimization .

How should researchers design control experiments when using NUBP2 Antibody, FITC conjugated?

Robust control experiments should include:

  • Negative controls: Samples treated with isotype-matched FITC-conjugated IgG from the same host species (rabbit)

  • Blocking peptide controls: Pre-incubation of the antibody with the immunizing peptide to confirm specificity

  • Positive controls: Samples known to express NUBP2 (based on literature)

  • siRNA knockdown controls: Comparing staining between NUBP2-silenced and normal cells

  • Cross-validation: Using alternative detection methods like western blot to confirm findings

These controls help distinguish specific binding from background fluorescence, particularly important with FITC conjugates which may exhibit some non-specific binding .

What counterstaining methods are compatible with NUBP2 Antibody, FITC conjugated?

DAPI (4′,6-diamidino-2-phenylindole) is highly compatible for nuclear counterstaining with FITC-conjugated antibodies, as demonstrated in similar applications . For multi-color imaging experiments, researchers should select counterstains with minimal spectral overlap with FITC's emission (519 nm). Compatible counterstains include propidium iodide (when using appropriate filter sets), DRAQ5, or far-red nuclear dyes. For organelle visualization, markers conjugated to fluorophores such as Texas Red, Cy3, or far-red dyes would minimize bleed-through issues when imaging NUBP2 localization.

How can researchers effectively study NUBP2's role in ciliogenesis using the FITC-conjugated antibody?

To investigate NUBP2's function in ciliogenesis, researchers can implement a multi-faceted approach:

  • Co-localization studies: Use the NUBP2 Antibody, FITC conjugated alongside markers for basal bodies (e.g., γ-tubulin) and ciliary structures (e.g., acetylated α-tubulin) using confocal microscopy

  • Temporal dynamics: Track NUBP2 localization throughout cell cycle phases, particularly during cilium formation and resorption

  • RNAi experiments: Combine NUBP2 knockdown with immunofluorescence to assess changes in cilia number and morphology

  • Rescue experiments: Reintroduce NUBP2 in knockdown cells to confirm specificity of observed phenotypes

Research has shown that downregulation of NUBP2 markedly increases the number of ciliated cells, confirming its role as a negative regulator of ciliogenesis .

What approaches can be used to study the interaction between NUBP2 and the CCT/TRiC molecular chaperone complex?

To explore NUBP2's interaction with the CCT/TRiC molecular chaperone complex, researchers can employ:

  • Co-immunoprecipitation: Using NUBP2 Antibody to pull down the protein complex, followed by western blot analysis for CCT/TRiC components

  • Proximity ligation assay (PLA): Combining NUBP2 Antibody, FITC conjugated with antibodies against CCT/TRiC components to visualize protein-protein interactions in situ

  • FRET analysis: Employing FITC-conjugated NUBP2 Antibody with acceptor fluorophore-labeled CCT/TRiC antibodies

  • Domain mapping: Using truncated NUBP2 constructs to identify specific interaction domains

  • Functional assays: Assessing how CCT/TRiC inhibition affects NUBP2 localization and function

Evidence indicates that NUBP2, along with NUBP1, interacts with several members of the CCT/TRiC molecular chaperone complex, which is enriched at the basal body and may play a role in ciliogenesis regulation .

How can researchers optimize dual immunofluorescence protocols involving NUBP2 Antibody, FITC conjugated?

For successful dual immunofluorescence involving NUBP2 Antibody, FITC conjugated:

  • Sequential staining: Apply unconjugated primary antibodies first, followed by non-FITC secondary antibodies, then apply the NUBP2 Antibody, FITC conjugated last

  • Cross-reactivity prevention: Use secondary antibodies raised against species different from the NUBP2 Antibody host (rabbit)

  • Fixation optimization: Test both paraformaldehyde (4%) and methanol fixation to determine optimal epitope preservation

  • Blocking optimization: Include normal serum from the species of all secondary antibodies in blocking solution

  • Signal amplification: Consider tyramide signal amplification if NUBP2 expression is low

  • Controls: Include single-stained samples to establish proper exposure settings and assess bleed-through

Proper optimization ensures clear distinction between NUBP2 and other proteins of interest while minimizing background and cross-reactivity .

What are common challenges when using FITC-conjugated antibodies and how can they be overcome?

Common challenges and solutions include:

ChallengeSolution
PhotobleachingMinimize light exposure; use anti-fade mounting media; capture FITC channel first in multi-channel imaging
High backgroundOptimize blocking (5% BSA or normal serum); reduce antibody concentration; increase washing steps
Weak signalOptimize fixation method; try antigen retrieval; increase antibody concentration or incubation time
AutofluorescenceUse Sudan Black B (0.1%) treatment; employ spectral unmixing; use confocal microscopy with narrow bandpass filters
pH sensitivityEnsure buffers maintain pH 7.4-8.0 (FITC fluorescence is optimal at alkaline pH)
Cross-reactivityPre-adsorb antibody; use more stringent washing; validate specificity with Western blot

These strategies can significantly improve the quality of data when working with FITC-conjugated NUBP2 antibody .

How should researchers interpret NUBP2 localization patterns in centrioles and cilia?

When interpreting NUBP2 localization in centrioles and cilia:

  • Spatial distribution: NUBP2 typically localizes to centrioles throughout the cell cycle and to the basal body of primary cilia

  • Co-localization analysis: Quantify overlap with established markers for specific centriolar/ciliary compartments

  • Cell cycle context: Interpret localization in the context of cell cycle stage (G0/G1 for primary cilia)

  • Comparison with NUBP1: Evaluate whether NUBP2 and NUBP1 show identical or distinct localization patterns

  • 3D reconstruction: Use z-stack imaging to fully capture the three-dimensional distribution

Research indicates that both NUBP1 and NUBP2 are integral components of centrioles throughout the cell cycle and localize at the basal body of primary cilia in quiescent cells, suggesting their role in regulating cilium formation .

What considerations are important when quantifying immunofluorescence results from NUBP2 Antibody, FITC conjugated staining?

For accurate quantification:

  • Signal-to-noise ratio: Calculate and report the ratio between specific signal and background

  • Dynamic range optimized imaging: Avoid pixel saturation by optimizing exposure times

  • Standardized acquisition: Maintain identical microscope settings across all experimental conditions

  • Thresholding methods: Document and consistently apply thresholding methods for signal detection

  • Normalization: Consider normalizing NUBP2 signal to a reference protein or structure

  • Technical replicates: Include multiple fields and biological replicates

  • Blinded analysis: Perform quantification blinded to experimental conditions to prevent bias

  • Statistical validation: Apply appropriate statistical tests based on data distribution

These practices ensure robust and reproducible quantification of NUBP2 expression and localization patterns .

How does NUBP2 function in the cytosolic iron-sulfur (Fe-S) protein assembly machinery?

NUBP2 functions as a key component of the cytosolic iron-sulfur (Fe-S) protein assembly (CIA) machinery. It forms a heterotetramer with NUBP1, creating a Fe-S scaffold complex that mediates the de novo assembly of Fe-S clusters and their transfer to target apoproteins. This process is essential for the maturation of extramitochondrial Fe-S proteins . Research approaches to study this function include:

  • Biochemical reconstitution: In vitro reconstitution of Fe-S cluster assembly with purified components

  • Spectroscopic analysis: UV-visible and EPR spectroscopy to monitor Fe-S cluster formation

  • Mutagenesis: Strategic mutations in NUBP2's nucleotide-binding motifs to assess functional requirements

  • Metabolic labeling: Using radioactive iron (⁵⁵Fe) to track the flow of iron through the Fe-S assembly pathway

  • Proteomic profiling: Identifying NUBP2-dependent changes in Fe-S proteome

Understanding NUBP2's role in Fe-S protein biogenesis provides insights into fundamental cellular processes dependent on these critical cofactors .

What is the relationship between NUBP2, NUBP1, and KIFC5A in regulating ciliogenesis?

The relationship between these proteins in ciliogenesis involves complex regulatory mechanisms:

  • Antagonistic functions: NUBP1/NUBP2 and KIFC5A appear to have opposing effects on ciliogenesis - knockdown of NUBP1/NUBP2 increases ciliated cells, while KIFC5A knockdown reduces ciliogenesis

  • Compensatory mechanisms: Double silencing of NUBP1 and KIFC5A restores the percentage of ciliated cells to control levels

  • Independent recruitment: NUBP1 and NUBP2 are recruited to centrioles independently of KIFC5A

  • Molecular interaction: KIFC5A is a minus-end directed motor protein that interacts with NUBP1/NUBP2

  • Temporal regulation: These proteins likely coordinate their activities during specific phases of the cell cycle to regulate ciliogenesis

This complex interplay suggests these proteins form a regulatory module controlling the balance of ciliogenesis, potentially through effects on basal body maturation or initiation of axoneme extension .

How can NUBP2 Antibody, FITC conjugated be used in live-cell imaging applications?

While challenging due to the need for intracellular delivery, live-cell applications could include:

  • Cell permeabilization techniques: Mild detergents, pore-forming toxins, or cell-penetrating peptides to introduce the antibody

  • Microinjection: Direct introduction of the antibody into individual cells

  • Electroporation: Temporary membrane disruption to allow antibody entry

  • Photoswitchable FITC derivatives: Using photoactivatable or photoswitchable FITC variants for pulse-chase experiments

  • Correlative microscopy: Live imaging followed by fixation and antibody staining to correlate dynamic events with NUBP2 localization

  • Proximity labeling: Combining with APEX2 or BioID approaches for temporal protein interaction studies

These approaches could provide valuable insights into the dynamic localization and function of NUBP2 during cellular processes like ciliogenesis or cell division .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.